Vesigen Therapeutics is a biotechnology company advancing groundbreaking therapies directed to intracellular targets using a fusogenic extracellular vesicle delivery technology. Our patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), is expanding the universe of druggable targets by enabling the delivery of a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and gene-editing complexes (Cas9/gRNA) directly into the cytoplasm of target cells. The team is committed to leveraging ARMMs technology to develop transformative medicines and address currently unmet medical needs.

Biotechnology

Vesigen Therapeutics

Vesigen Therapeutics' headquarters in Cambridge, MA, United States

Paulash Mohsen

Lorien Moore

Qiyu W.

Gang (Gary) Hao

Gerald Chan

Stephen Bruso

Jürgen Eckhardt

Quan Lu

Dieter Weinand

Lucio Iannone

Stephen J. Haggarty

Rakhshita Dhar

Kate Fitzgerald

Connie Cepko

Description

People (1)

Jason Dinges

Jobs